Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,091,030
+$1,874,095 QoQ
Shares Held
5,912
+4.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#1,461
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SMITH, MOORE & CO. holds $27,430,178 across 9 Drug Manufacturers - General names. LLY ranks #2 (25.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
28,543 | $7,182,560 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
5,912 | $7,091,030 | |
| 3 | JNJ |
Johnson & Johnson
|
23,180 | $5,887,024 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,976 | $3,080,916 | |
| 5 | AMGN |
Amgen Inc
|
4,729 | $1,712,465 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,730 | $906,362 | |
| 7 | PFE |
Pfizer Inc
|
32,201 | $775,400 | |
| 8 | AZN |
Astrazeneca PLC
|
2,644 | $501,355 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,091,030 | 5,912 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,216,935 | 5,672 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $6,142,871 | 5,716 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $4,703,895 | 6,165 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,563,368 | 5,854 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,322,989 | 6,445 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,792,316 | 7,503 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,341,784 | 8,287 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,540,004 | 8,328 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,060,764 | 9,076 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,686,093 | 8,039 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,148,792 | 7,724 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $3,598,952 | 7,674 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,170,757 | 6,321 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,972,975 | 5,393 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,725,072 | 5,335 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,802,070 | 5,558 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,821,026 | 6,359 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,742,395 | 6,308 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,378,675 | 5,967 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,317,215 | 5,739 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,075,896 | 5,759 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $940,269 | 5,569 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $913,283 | 6,170 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $924,497 | 5,631 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $659,474 | 4,754 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||